“Stereotactic Radiotherapy in Combination With the Immunoconjugate Trastuzumab Emtansine in Patients With HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study”. Voprosy Onkologii, vol. 72, no. 3, July 2026, p. OF-2696, https://doi.org/10.37469/0507-3758-2026-72-3-OF-2696.